Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H2 2025

European Healthtech startup funding raised during H2 2025.

In H2 2025, 198 European Healthtech companies closed 200 funding rounds and raised €3.5B in equity funding (excluding debt and grants), up 23.5% versus H2 2024. Debt rounds added €126M. UK led by capital raised, and YZR Capital was the most active investor. Data as of 20 Nov 2026.

Equity funding
€3.5B
+23.5% vs H2 2024 · excl. debt & grants · +€126M debt
Funding rounds
200
-1.0% vs H2 2024
Companies
198
Top country
UK
Rank among sectors
#5
9.6% of sector funding
Debt financing
€126M
3.4% of total
Top-10 round share
52.6%
of disclosed capital
Rounds ≥ €100M
5

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H2 2025 — interactive chart.
Data table
FundingRounds
Jul€420M43
Aug€514M23
Sep€537M44
Oct€1.7B47
Nov€442M26
Dec€128M17

Top countries

by € raised
Healthtech — top countries by capital, H2 2025 — interactive chart.
Data table
Healthtech — top countries by capital, H2 2025
UK€864M
Finland€787M
Germany€629M
Switzerland€488M
Spain€146M
Netherlands€144M
France€128M
Ireland€125M

Stage mix

by € raised
Healthtech — stage mix, H2 2025 — interactive chart.
Data table
Healthtech — stage mix, H2 2025
Series D+€1.1B
Other€919M
Series A€531M
Series B€451M
Series C€366M
Seed€143M
Debt€126M
Grant€58M
Growth/Late€24M
Pre-Seed€19M

Exits & M&A

15 Acquisition · 1 IPO

16 exits · €9.3B disclosed.

MerusAcquisitionSep 2025€6.8B
VicebioAcquisitionJul 2025€1.4B
Imcheck TherapeuticsAcquisitionOct 2025€1.0B
PharvarisIPOJul 2025€172M

Top deals

largest disclosed rounds in H2 2025
CompanyStageDateAmount
Oura HealthSeries D+Oct 2025€774M
Tubulis TechnologiesSeries COct 2025€308M
OrtivityOtherAug 2025€200M
DistalMotionSeries D+Nov 2025€130M
OculisDebtAug 2025€106M
ArtiosSeries D+Nov 2025€99M
CoMindSeries AOct 2025€86M
NUCLIDIUMSeries BJul 2025€84M
NanoPhoriaSeries AOct 2025€84M
TrogenixSeries AOct 2025€80M
ViCentraSeries D+Sep 2025€73M
ProVerumSeries BAug 2025€68M
NRG TherapeuticsSeries BSep 2025€58M
MRM HealthSeries BSep 2025€55M
AMSilkOtherSep 2025€52M

Top investors

most active in H2 2025, by deal count